skip to Main Content

What’s to Come in MolDx?

Summary

Meet Kathy Hughes who leads our Molecular Diagnostics team and has successfully advised device, diagnostics and pharmaceutical companies on optimal market access strategies for over a decade. Kathy addresses key evidentiary developments in the diagnostics space, and what she sees as the future of this evolving field.

Panelists

Speaker
Kathy Hughes , Vice President, Market Access & Reimbursement

Kathy Hughes advises Avalere clients on value strategies, market access, and evidence planning.

From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top